← Back to all articles

Articles · Earnings, Guidance Tracker

Zimmer Biomet (ZBH) Q3 2026 Earnings: Guidance Raised

Q3 2026 (ended Sep 30, 2026): revenue, EPS and full-year guidance from the SEC filing

Published Nov 5, 2026

TL;DR

  • Zimmer Biomet raised its full-year guidance; revenue +3.1% vs a year earlier.

Zimmer Biomet's results for Q3 2026 (ended Sep 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-11-04. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.

At a glance

ItemValue
Revenue (GAAP)$2,063 million (+3.1% vs a year earlier)
Diluted EPS (GAAP)$1.00
Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs)$1.90
Full-year guidanceRaised

Guidance

Raised 2026 adjusted EPS guidance to $8.50–$8.60 from $8.47–$8.59 and organic constant-currency revenue growth to 3.0%–3.5%.

Why this label: CEO: 'confidence to raise our full-year organic constant-currency sales growth and adjusted EPS guidance'; table: adjusted EPS $8.50-8.60 vs $8.47-8.59; organic growth 3.0-3.5% vs 2.25-3.25%.

MetricPeriodNewPrior (as stated in the release)
reported revenue changeFY20264.4%–4.9%3.9%–4.9%
constant currency revenue changeFY20264.1%–4.6%3.4%–4.4%
organic constant currency revenue changeFY20263.0%–3.5%2.25%–3.25%
adjusted diluted EPSFY2026$8.50–$8.60$8.47–$8.59

From the release

Revenue: "Net Sales · $ · 2,062.9 · $ · 2,001.4"

Earnings per share: "Third quarter diluted earnings per share were $1.00, a decrease of 13.8%; adjusted 1 diluted earnings per share were $1.90"

reported revenue change: "2026 Reported Revenue Change · 3.9% - 4.9% · 4.4% - 4.9%"

constant currency revenue change: "2026 Constant Currency Revenue Change · 3.4% - 4.4% · 4.1% - 4.6%"

organic constant currency revenue change: "2026 Organic Constant Currency Revenue Change (1) · 2.25% - 3.25% · 3.0% - 3.5%"

Quotes are copied from the filing; in table rows, cell borders are shown as “·”.

Key fact: Raised 2026 organic constant-currency sales growth guidance to 3.0%–3.5% from 2.25%–3.25%.

Source

Zimmer Biomet earnings release (SEC filing), accession 0001193125-26-446145, filed 2026-11-04.

Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.

Get the Sunday Recap by email

One email a week. Every issue is published on the site too, so this is only about getting it in your inbox.

Subscribing signs you up for the free YieldTerminal Sunday recap, one email a week. Educational only, not financial advice. Unsubscribe any time.

Educational commentary, not a recommendation to buy or sell anything.